Estimating the health workforce requirements and costing to reach 70% COVID-19 vaccination coverage by mid-2022: a modelling study and global estimates.


Journal

BMJ open
ISSN: 2044-6055
Titre abrégé: BMJ Open
Pays: England
ID NLM: 101552874

Informations de publication

Date de publication:
05 08 2022
Historique:
medline: 15 8 2023
pubmed: 14 8 2023
entrez: 14 8 2023
Statut: epublish

Résumé

The implementation of COVID-19 vaccination globally poses unprecedented stress to health systems particularly for countries with persisting health workforce shortages prior the pandemic. The present paper estimates the workforce requirement to reach 70% COVID-19 vaccination coverage in all countries by mid-2022 using service target-based estimation. Health workforce data from National Health Workforce Accounts and vaccination coverage reported to WHO as of January 2022 were used. Workload parameters were used to estimate the number of health workers needed with a service target-based approach, the gap and the scale-up required partially accounting for countries' challenges, as well as the associated costs in human resources. As of 1 January 2022, only 34 countries achieved 70% COVID-19 vaccination coverage and 61 countries covered less than a quarter of their population. This analysis showed that 1 831 000 health workers working full time would be needed to reach a global coverage of 70% COVID-19 vaccination by mid-2022. To avoid severe disruptions to health system, 744 000 additional health workers should be added to domestic resources mostly (77%) in low-income countries. In a sensitivity analysis, allowing for vaccination over 12 months instead of 6 months would decrease the scale-up to 476 000 health workers. The costing for the employment of these 744 000 additional health workers is estimated to be US$2.5 billion. In addition to such a massive scale-up, it is estimated that 29 countries would have needed to redeploy more than 20% of their domestic workforce, placing them at serious risk of not achieving the mid-year target. Reaching 70% global coverage with COVID-19 vaccination by mid-2022 requires extraordinary efforts not before witnessed in the history of immunisation programmes. COVID-19 vaccination programmes should receive rapid and sustainable investment in health workforce.

Identifiants

pubmed: 37574719
pii: bmjopen-2022-063059
doi: 10.1136/bmjopen-2022-063059
pmc: PMC9361754
doi:

Substances chimiques

COVID-19 Vaccines 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

e063059

Subventions

Organisme : World Health Organization
ID : 001
Pays : International

Informations de copyright

© Author(s) (or their employer(s)) 2022. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.

Déclaration de conflit d'intérêts

Competing interests: None declared.

Références

Hum Resour Health. 2022 Jan 28;19(Suppl 1):152
pubmed: 35090485
Lancet Glob Health. 2018 Feb;6(2):e152-e168
pubmed: 29248365
Nat Med. 2021 Aug;27(8):1385-1394
pubmed: 34272499
Vaccine. 2021 Jul 22;39(32):4564-4570
pubmed: 33744046
Cost Eff Resour Alloc. 2018 Mar 19;16:11
pubmed: 29559855
Health Policy Plan. 2005 Sep;20(5):267-76
pubmed: 16076934

Auteurs

Mathieu Boniol (M)

Health Workforce Department, World Health Organization, Geneva, Switzerland boniolm@who.int.

Amani Siyam (A)

Health Workforce Department, World Health Organization, Geneva, Switzerland.

Shalini Desai (S)

Immunization, Vaccines & Biologicals Department, World Health Organization, Geneva, Switzerland.

Santosh Gurung (S)

Immunization, Vaccines & Biologicals Department, World Health Organization, Geneva, Switzerland.

Andrew Mirelman (A)

Health System Governance and Financing Department, World Health Organization, Geneva, Switzerland.

Tapas Sadasivan Nair (TS)

Health Workforce Department, World Health Organization, Geneva, Switzerland.

Khassoum Diallo (K)

Health Workforce Department, World Health Organization, Geneva, Switzerland.

James Campbell (J)

Health Workforce Department, World Health Organization, Geneva, Switzerland.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH